
Sign up to save your podcasts
Or


Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.
By The Lancet NeurologyTobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.

43,524 Listeners

302 Listeners

527 Listeners

55 Listeners

112,988 Listeners

90 Listeners

515 Listeners

187 Listeners

58 Listeners

82 Listeners

0 Listeners